Latest Strategy Changes News

Page 60 of 932
Corazon Mining has secured two critical tenements at its Two Pools Gold Project in Western Australia, enabling preparations for a maiden diamond drilling program aimed at confirming high-grade gold mineralisation early next year.
Maxwell Dee
Maxwell Dee
28 Nov 2025
Emeco Holdings has refinanced its long-term debt with a new A$355 million facility, extending maturity and improving terms to support future growth.
Maxwell Dee
Maxwell Dee
28 Nov 2025
Everest Metals Corporation has reported impressive rubidium assay results up to 0.79% Rb₂O from its Phase 2 drilling at the Mt Edon Critical Mineral Project, reinforcing the potential for resource expansion ahead of a planned upgrade in early 2026.
Maxwell Dee
Maxwell Dee
28 Nov 2025
Aquirian’s subsidiary TBS Mining Solutions has inked a $4.2 million deal with Papyrus Australia to manufacture biodegradable Collar Keeper® products, marking a significant step in sustainable mining practices.
Maxwell Dee
Maxwell Dee
28 Nov 2025
Altech Batteries Limited has undergone a significant board and management reshuffle following a shareholder-led challenge, appointing new leadership while reaffirming its strategic focus on advanced battery technologies.
Maxwell Dee
Maxwell Dee
28 Nov 2025
TruScreen Group Limited reported a 17% decline in first half FY2026 product sales but affirmed full-year revenue guidance at NZ$2.8 million, supported by strategic expansions and a successful NZ$4 million capital raise.
Ada Torres
Ada Torres
28 Nov 2025
VEEM Limited reported a year of consolidation in FY25 with solid second-half growth driven by new defence contracts and the promising launch of its VEEM Extreme propulsion system. Despite a revenue dip, the company is poised for a stronger FY26 backed by strategic US defence partnerships and product innovation.
Victor Sage
Victor Sage
27 Nov 2025
Joyce Group reported solid FY25 results with strong revenue growth and a 20% expansion in KWB showrooms, alongside a key leadership transition at KWB.
Logan Eniac
Logan Eniac
27 Nov 2025
Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.
Ada Torres
Ada Torres
27 Nov 2025
QGold Pty Ltd has initiated an unconditional on-market takeover offer for all shares in Venus Metals Corporation Limited at a 21% premium, aiming to consolidate control and potentially delist the explorer.
Maxwell Dee
Maxwell Dee
27 Nov 2025
QGold Pty Ltd has launched an unconditional on-market takeover offer for all shares of Venus Metals Corporation Limited at a 21% premium, providing shareholders with immediate cash liquidity. The offer, backed by a substantial funding arrangement, signals potential strategic shifts for Venus Metals.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Hexima Limited reveals plans to return capital to shareholders and restructure its board following the closure of its main clinical program and prolonged ASX trading suspension.
Ada Torres
Ada Torres
27 Nov 2025